Agilent launches new microarrays for cytogenetic testing

By The Science Advisory Board staff writers

March 3, 2020 -- Agilent Technologies has unveiled three new microarrays to support pre- and postnatal research by cytogenetic laboratories.

The GenetiSure Cyto microarrays feature updated and clinically relevant content from respected databases, according to the firm. In addition, the microarray probes yield high-resolution detection of copy number variations and copy-neutral loss of heterozygosity associated with developmental delays, neuropsychiatric disorders, intellectual disability, congenital anomalies, or unexplained dysmorphic features in constitutional DNA samples, Agilant said.

What's more, the new arrays utilize different specifications -- depending on if they are being used for pre- or postnatal research -- to focus on clinically relevant regions. The arrays can achieve up to exon-level resolution, according to the firm.

Agilent to fund biotherapy incubator in India
Agilent Technologies has announced a partnership with the Indian Institute of Technology Delhi to advance biotherapeutic research in the country.
Agilent unveils SureSelect DNA kit
Agilent Technologies has debuted SureSelect XT HS2, a DNA kit designed to help laboratories prepare DNA sequencing libraries for cancer and genetics research.
Software improves compatibility and efficiency in chromatography
On January 2, Thermo Fisher Scientific and Agilent Technologies announced their continued agreement to the industry-wide Instrument Control Exchange Program...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter